ArticleAACE clinical case reports

NEOADJUVANT LENVATINIB IN ADVANCED UNRESECTABLE MEDULLARY THYROID CARCINOMA: A CASE REPORT.

Hubert Golingan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.